COGNICURRENT

Polish pharmaceutical industry leaders express concerns over the increasing reliance on Chinese-produced active pharmaceutical ingredients (APIs), warning it poses a significant threat to the security of medication supplies in Europe.

The article discusses the issue of pharmaceutical compounds contaminating the environment, primarily through wastewater and improper disposal, and highlights recent studies in Lithuania that reveal their presence in various water sources.

A pharmaceutical distributor in Ribeirão Preto reported a theft of over R$ 572,000 in oncology and hemotherapy medications.

Asahi Kasei has announced its acquisition of the German pharmaceutical development company Aiquiris for approximately €780 million, marking its third acquisition in the pharmaceutical sector since 2020.

The president of the Supreme Pharmaceutical Council of Poland warns that the lifting of the advertising ban for pharmacies, following a European Court ruling, has led to dangerous and irresponsible marketing practices.

Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.

Brazilian pharmaceutical firms Biomm and Amoveri are pursuing Indian technology agreements to produce weight loss pens ahead of the patent expiration for Ozempic in 2026.

Indian pharmaceutical company Dr. Reddy’s Laboratories is set to launch a generic version of the diabetes drug Ozempic, named Obeda, in March 2026 following the expiration of the semaglutide patent.

Brazil's President Lula da Silva is visiting India to address the country's significant deficit in pharmaceutical supplies, aiming to transfer technology to enhance the local healthcare industry.

The expiration of the semaglutide patent in March is expected to lead to a price reduction of up to 35% for Ozempic, according to pharmaceutical company EMS, which is interested in producing a generic version.

The Hiroshima Carp baseball team announced the termination of infielder Ryutaro Hazuki's contract due to his indictment for violating pharmaceutical regulations related to a substance known as 'zombie tobacco.'

The local veterinary pharmaceutical industry is vital for national health and food security, and its decline poses significant risks due to increased dependency on imports.

Brazil's pharmaceutical retail sector generated approximately R$ 128.6 billion in 2025, bolstered by the popularity of weight-loss pens like Mounjaro, Ozempic, and Wegovy.

A significant shortage of the widely used blood thinner apixaban has occurred in Finland's pharmacies due to a patent dispute among pharmaceutical companies, leaving only the original, more expensive version available.

The Swedish Dental and Pharmaceutical Benefits Agency has rejected a subsidy application for the obesity medication Wegovy from Novo Nordisk.

Juan Toral Sánchez critiques the food and pharmaceutical industries' influence on public health, suggesting they profit from perpetuating a culture of illness.

The article discusses the personal experience of Tamar Abrams, who turned to Ozempic, a diabetes medication associated with weight loss, due to health issues stemming from personal hardships and the influence of advertising.

Shandong Xinhua Pharmaceutical's shares surged due to a viral dance challenge but are now suffering as profits decline amid oversupply and weak demand for their products.

Belén Garijo returns to Sanofi as CEO after a successful tenure at Merck, marking a significant transition in her career as she continues to shape the pharmaceutical industry.

The Polish Chief Pharmaceutical Inspector has announced the withdrawal of popular antiseptic Octenisept from pharmacies due to the circulation of counterfeit products.

The article discusses the skepticism surrounding the pharmaceutical and food industry funding of medical research and the evolution of medical research practices over the years.

Brazil's health regulatory agency, Anvisa, reports 65 suspected deaths linked to the use of weight loss pens from December 2018 to December 2025, with a significant increase in reported adverse events.

The article discusses the evolving role of CFOs in the pharmaceutical industry, emphasizing their shift from cost control to being strategic partners in decision-making.

Dr. Karolina Czekaj emphasizes the evolving role of CFOs in the pharmaceutical sector, highlighting their strategic importance beyond just expense management.

The pharmaceutical company Zynex has reached a settlement with U.S. authorities admitting to healthcare fraud and other securities-related fraud.

Donald Trump's recent presidential decree classifies glyphosate-based herbicides as essential for U.S. national security, benefiting the pharmaceutical company Bayer.

The Pharmaceutical Enterprises Group Tsetis (OFET) is enhancing its presence in the Middle East by actively participating in major health expos, most notably the WHX Dubai.

Profarm announces the acquisition of Dynamic Pharmacy Warehouse, aiming to transform the wholesale market in Greece while maintaining the existing management and identity of Dynamic Pharmacy.

Pharmaceutical companies in Brazil criticize a proposal to extend the patent duration of medications, arguing it could increase healthcare costs and reduce access.

Big pharmaceutical companies like Moderna are increasing investment in Mexico due to a measles outbreak that has claimed 31 lives and exceeded 10,000 cases.

The article discusses the significant evolution of Mexico's pharmaceutical industry over the past 81 years, highlighting its role in producing safe and effective medications for both national and international markets.

Kyriakos Souliotis has been appointed as the president of the Advisory Committee at the Academy of Pharmacy by Greece’s Ministry of Education.

Dong Sung Pharmaceutical has been sanctioned by the Fair Trade Commission for providing approximately 250 million won in illegal rebates to doctors in the Seoul metropolitan area over a nine-year period.

Bayer, the German pharmaceutical company, faces a potential billion-dollar settlement regarding lawsuits tied to glyphosate, a weed killer linked to cancer claims.

An Indian pharmaceutical company is set to launch generic versions of obesity drugs Ozempic and Wegony at significantly reduced prices in India.

Three pharmaceutical companies in Marburg are cutting hundreds of jobs, though it may not negatively impact the city's finances.

Greece's rapidly growing pharmaceutical sector is investing heavily in innovation, driven by strategic mergers, acquisitions, and access to the U.S. market.

Without the pharmaceutical industry, the EU's trade balance would shift from a surplus of 147 billion euros to a deficit of 47 billion euros, according to the EFPIA.

International and Greek pharmaceutical mergers and acquisitions are on the rise, focusing on innovative drugs and expiring patents.

Lavipharm has partnered with DIS to implement a comprehensive Microsoft Dynamics 365 Finance & Supply Chain Management project as part of its digital transformation efforts.

A former pharmaceutical executive claims that activating certain cells and hormones through a specific diet can be as effective for weight loss as taking Ozempic, a popular medication.

Holger Moe Tørisen, a prominent figure in Norwegian pharmacy, passed away on February 1, 2026, leaving behind a significant legacy in the field.

Researchers at the University of Marburg have developed a blood test that aims to reduce stress for laboratory mice used in drug testing by allowing for less invasive monitoring of tumor growth.

Sen. Tom Cotton is urging the FDA to investigate the infiltration of illegal Chinese ingredients into weight loss drugs sold in the United States, citing national and health security concerns.

President Lula is visiting Greater Recife to attend a pharmaceutical factory opening and a local cultural event.

China has formally charged former AstraZeneca executive Leon Wang with multiple offenses, highlighting pressures facing foreign pharmaceutical companies in a tightening regulatory environment.

The head of the Pharma Dialogue, Dorothee Brakmann, proposes a plan that could potentially save health insurers four billion euros while highlighting the stagnation in discussions between the pharmaceutical industry, health insurers, and the government.

Belén Garijo, the departing CEO of Merck, is set to lead the French pharmaceutical giant Sanofi following the sudden exit of its former CEO, Paul Hudson.

Paul Hudson has been replaced as CEO of Sanofi by Belén Garijo amid concerns over the company's research and development progress.

Danish pharmaceutical company Novo Nordisk has sued American company Hims & Hers, accusing it of selling an 'unsafe' copy of its weight loss drug.